Business Context and Reporting Period
Seastar Medical Holding Corp (ICU) filed a Form 8-K on August 6, 2025, reporting an event that occurred on July 31, 2025. The company is incorporated in Delaware and its common stock and warrants trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding listing status and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The material change reported is the receipt of a deficiency letter from Nasdaq. The Company's common stock closing bid price remained below the minimum $1.00 per share requirement for 30 consecutive business days prior to July 31, 2025, violating Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has been granted an initial 180-calendar day period to regain compliance, with a deadline of January 27, 2026.
- Remediation Path: Compliance can be achieved if the closing bid price reaches at least $1.00 for a minimum of 10 consecutive business days before the compliance date.
- Management Action: Management intends to monitor the stock price and may consider available options to regain compliance.
- Immediate Impact: The notification has no immediate effect on the Company's Nasdaq listing.
Investor Verification Checklist
- Verify the current closing bid price of ICU common stock to assess proximity to the $1.00 threshold.
- Monitor the stock price for 10 consecutive business days to determine if the Company can secure early compliance confirmation.
- Review subsequent filings for any announcements regarding reverse stock splits or other capital structure changes intended to address the bid price deficiency.
- Confirm the exact date of the compliance deadline (January 27, 2026) to track the remaining window for remediation.